Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia.

Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia. Expert Opin Drug Saf. 2022 Jan; 21(1):9-20.

View in: PubMed